Crossmark

Lost in third space: altered tyrosine-kinase inhibitor pharmacokinetics in a patient with malignant ascites

Published Online: 2021-12-01

Published Print: 2022-02

Authors

Krens, Stefanie D. https://orcid.org/0000-0002-4406-7149
Mulder, Sasja F.

van Erp, Nielka P.
License Information

Text and Data Mining valid from 2021-12-01

Version of Record valid from 2021-12-01
More Information

Article History

Received: 18 October 2021

Accepted: 20 November 2021

First Online: 1 December 2021

Declarations

:

: All mentioned relationships are outside of the submitted work and invoiced by the institution. SFM has received honoraria from Pfizer, Roche, Merck Sharp and Dohme and Bristol Meyers Squibb. NPvE had received research grants from Novartis, Astellas, Janssen-Cilag, Pfizer, Ipsen, has been on an advisory board for Pfizer, and received honoraria from Bayer and Sanofi. SDK declared no conflict of interest.

Document is current